Register
Forgot your password?

Fibromuscular dysplasia of renal arteries (modernmethods of diagnosis and treatment)

Authors: Gasymov E.G., Abdulgasanov R.A.

Company: 1Bakoulev National Medical Research Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation;
2 A.I. Evdokimov Moscow State Medical-Stomatological University of Ministry of Health of the Russian Federation, Delegatskaya ulitsa, 20, stroenie 1, Moscow, 127473, Russian Federation

For correspondence:  Sign in or register.

Type:  Vascular diseases


DOI: https://doi.org/10.24022/1997-3187-2018-12-1-62-69

For citation: Gasymov E.G., Abdulgasanov R.A. Fibromuscular dysplasia of renal arteries (modern methods of diagnosis and treatment). Creative Cardiology (Kreativnaya Kardiologiya). 2018; 12 (1): 62–9 (in Russ.). DOI: 10.24022/1997-3187-2018-12-1-62-69.

Received / Accepted:  28.08.2017/04.09.2017

Keywords: fibromuscular dysplasia renovascular hypertension diagnostics treatment

Full text:  

 

Abstract

Fibromuscular dysplasia is a rare noninflammatory vascular disease characterized by nonatheroslerotic stenosis predominantly seen in young women, whereas the majority of cases involve the renal arteries causing secondary hypertension. Most noninvasive screening tests are not quite sensitive or reproducible to rule out renal artery stenosis, but renal angiography usually confirms the diagnosis. Percutaneous renal artery angioplasty is the treatment of choice; however, it may not result in normalization of blood pressure if diagnosis is delayed. Continued follow-up is necessary since stenosis reoccurs.

References

  1. Shivapour D.M., Erwin P., Kim E.S. Epidemiology of fibromuscular dysplasia: A review of the literature. Vasc. Med. 2016; 21: 376–81.

  2. Bumpus S.M., Kuck C., Heidt S.T. Diagnosed and living with fibromuscular dysplasia: A qualitative Inquiry. Vasc Med. 2016; 21: 539–46.

  3. Chiong J.R., Aronow W.S., Khan I.A. et al. Secondary hypertension: current diagnosis and treatment. Int. J. Cardiol. 2008; 124: 6–21.

  4. Bloch M.J., Basile J. Clinical insights into the diagnosis and management of renovascular disease. An evidence-based review. Minerva Med. 2004; 95: 357–73.

  5. Olin J.W., Gornik H.L., Bacharach J.M. et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014; 129: 1048–78.

  6. Sang C.N., Whelton P.K., Hamper U.M. et al. Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. Hypertension. 1989; 14: 472–9.

  7. Plouin P.F., Perdu J. Fibromuscular dysplasia. Orphanet. J. Rare Dis. 2007; 2: 28.

  8. McCormack L.J., Poutasse E.F., Meaney T.F. et al. A pathologic-arteriographic correlation of renal arterial disease. Am. Heart J. 1966; 72: 188–98.

  9. Lassiter F.D. The string-of-beads sign. Radiology. 1998; 206: 437–8.

  10. Olin J.W., Froehlich J., Gu X. et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012; 125: 3182–90.

  11. Pannier-Moreau I., Grimbert P., Fiquet-Kempf B. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J. Hypertens. 1997; 15: 1797–801.

  12. Bofinger A., Hawley C., Fisher P. et al. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J. Hum. Hypertens. 2001; 15: 185–90.

  13. Slovut D.P. Fibromuscular dysplasia. N. Engl. J. Med. 2004; 350: 1862–71.

  14. Luscher T.F., Lie J.T., Stanson A.W. Arterial fibromuscular dysplasia. Mayo Clin. Proc. 1987; 62: 931–52.

  15. Beregi J.P., Louvegny S., Gautier C. et al. Fibromuscular dysplasia of the renal arteries: comparison of helical CT angiography and arteriography. AJR Am. J. Roentgenol. 1999; 172: 27–34.

  16. Kincaid O.W., Davis G.D., Hallermann F.J. Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1968; 104: 271–82.

  17. Savard S., Steichen O., Azarine A. et al. Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics. Circulation. 2012; 126: 3062–9.

  18. Paris B., Bobrie G., Rossignol P. et al. Blood pressure and renal outcomes in patients with kidney infarction and hypertension. J. Hypertens. 2006; 24: 1649–54.

  19. Kim E.S., Olin J.W., Froehlich J.B. et al. Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia. J. Am. Coll. Cardiol. 2013; 62: 2026–8.

  20. Turnbull J.M. The rational clinical examination. Is listening for abdominal bruits useful in the evaluation of hypertension? JAMA. 1995; 274: 1299–301.

  21. Sharma A.M., Kline B. The United States registry for fibromuscular dysplasia: new findings and breaking myths. Tech. Vasc. Interv. Radiol. 2014; 17: 258–63.

  22. Zeller T. Renal artery stenosis: epidemiology, clinical manifestation, and percutaneous endovascular therapy. J. Interv. Cardiol. 2005; 18: 497–506.

  23. Schoenberg S.O., Essig M. Comprehensive MR evaluation of renovascular disease in five breath holds. J. Magn. Reson. Imaging. 1999; 10: 347–56.

  24. Willoteaux S., Faivre-Pierret M., Moranne O. et al. Fibromuscular dysplasia of the main renal arteries: comparison of contrast-enhanced MR angiography with digital subtraction angiography. Radiology. 2006; 241: 922–9.

  25. Meuse M.A., Turba U.C., Sabri S.S. et al. Treatment of renal artery fibromuscular dysplasia. Tech. Vasc. Interv. Radiol. 2010; 13: 126–33.

  26. Mousa A.Y., Gill G. Renal fibromuscular dysplasia. Semin. Vasc. Surg. 2013; 26: 213–8.

  27. Hirsch A.T., Haskal Z.J., Hertzer N.R. et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006; 113: e463–654.

  28. Safian R.D., Textor S.C. Renal-artery stenosis. N. Engl. J. Med. 2001; 344: 431–42.

  29. Colyer W.R., Eltahawy E., Cooper C.J. Renal artery stenosis: optimizing diagnosis and treatment. Prog. Cardiovasc. Dis. 2011; 54: 29–35.

  30. Dorros G., Jaff M., Mathiak L. Four-year followup of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998; 98: 642–7.

  31. Dorros G., Jaff M., Mathiak L. Multicenter Registry P. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1058 successful patients. Cathet. Cardiovasc. Interv. 2002; 55: 182–8.

  32. Zeller T., Muller C., Frank U. et al. Survival after stenting of severe atherosclerotic ostial renal artery stenoses. J. Endovasc. Ther. 2003; 10: 539–45.

  33. Zeller T., Frank U., Muller C. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J. Endovasc. Ther. 2004; 11: 95–106.

  34. Wheatley K., Ives N., Gray R. et al. Revascularization versus medical therapy for renalartery stenosis. N. Engl. J. Med. 2009; 361: 1953–62.

  35. Bax L., Woittiez A.J., Kouwenberg H.J. et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann. Intern. Med. 2009; 150: 840–8, W150–1.

  36. Van Jaarsveld B.C., Krijnen P., Pieterman H. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N. Engl. J. Med. 2000; 342: 1007–14.

  37. Mousa A.Y., Campbell J.E., Stone P.A. et al. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. J. Vasc. Surg. 2012; 55: 421–7.

  38. Gavalas M.V., Gasparis A.P., Tassiopoulos A.K. et al. Long-term follow-up for percutaneous transluminal angioplasty in renal artery fibromuscular dysplasia. Int. Angiol. 2015; 34 (6): 529–37 [Epub ahead of print 2014].

  39. Fujihara M., Fukata M., Higashimori A. et al. Short- and mid-term results of balloon angioplasty for renal artery fibromuscular dysplasia. Cardiovasc. Interv. Ther. 2014; 29: 293–9


About Authors

  • Gasymov Emil' Gadirovich, Student, Male Nurse, orcid.org/0000-0001-6430-9590;
  • Abdulgasanov Ramiz Alievich, Dr Med. Sc., Chief Researcher, orcid.org/0000-0002-2126-3139

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by